Risk factors for asthma onset between the ages of 12 and 40. results of the FENASMA study;Factores de riesgo de asma de inicio entre los 12 y 40 años. Resultados del estudio FENASMA

Archivos de Bronconeumologia

Volumn 47, Issue 9, 2011, Pages 433-440

  Pelta Fernández, Roberto ^a   De Miguel Díez, Javier ^a   Álvarez Perea, Alberto ^a   Magán Tapia, Purificación ^b   Jiménez García, Rodrigo ^c   Sanz De Burgoa Gómez Piñán, Verónica ^d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

^d PFIZER INC   (United States)

Author keywords

Adults; Asthma; Risk factors

Indexed keywords

ALLERGEN; NONSTEROID ANTIINFLAMMATORY AGENT; IRRITANT AGENT;

ADULT; AGE DISTRIBUTION; ALLERGY; ARTICLE; ASTHMA; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; ONSET AGE; RHINITIS; RISK ASSESSMENT; RISK FACTOR; ADOLESCENT; CHILD; DISEASE COURSE; HYPERSENSITIVITY;

EID: 85047698997     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2011.04.009     Document Type: Article

References (39)

1. Eder W., Ege M.J., Von Mutius E. The asthma epidemic. N Engl J Med 2006, 355:2226-2235.
2. Bel E.H. Clinical phenotypes of asthma. Curr Opin Pulm Med 2004, 10:44-50.
3. Janson C., Anto J., Burney P., Chinn S., De Marco R., Heinrich J., et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001, 18:598-611.
4. Global strategy for asthma management and prevention - updated 2009. Disponible en: http://www.ginasthma.com/.
5. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31:143-178.
6. Abramson M., Kutin J.J., Raven J., Lanigan A., Czarny D., Walters E.H. Risk factors for asthma among young adults in Melbourne, Australia. Respirology 1996, 1:291-297.
7. Grossman J. One airway, one disease. Chest 1997, 111:11S-16S.
8. Guerra S., Sherrill D.L., Martinez F.D., Barbee R.A. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002, 109:419-425.
9. Miller M.R., Crapo R., Hankinson J., Brusasco V., Burgos F., Casaburi R., et al. American Thoracic Society and European Society Task Force: Standardization of lung function testing. General considerations for lung function testing. Eur Resp J 2005, 26:153-161.
10. Vega J.M., Badia X., Badiola C., López-Viña A., Olaguibel J.M., Picado C., et al. Validation of the Spanish version of the Asthma Control Test (ACT). J Asthma 2007, 44:867-872.
11. Ferrer M., Alonso J., Prieto L., Plaza V., Monso E., Marrades R., et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respiratory Soc 1996, 9:1160-1166.
12. Blanco-Aparicio M., Vázquez-Rodríguez I., Verea-Hernando H. [Cultural adaptation into Spanish of the airways questionnaire 20, a short health-related quality-of-life questionnaire for the clinical evaluation of asthma and chronic obstructive pulmonary disease]. Arch Bronconeumol 2009, 45:24-29.
13. World Health Organization. Obesity: Preventing and managing the global epidemic: Report of a WHO consultation on obesity. WHO technical report series 894. Ginebra: WHO; 2000.
14. Taylor B., Mannino D., Brown C., Crocker D., Twum-Baah N., Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008, 63:14-20.
15. De Marco R., Marcon A., Jarvis D., Accordini S., Almar E., Bugiani M., et al. Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol 2006, 117:1249-1256.
16. Apter A.J. The influence of health disparities on individual patient outcomes: what is the link between genes and environment?. J Allergy Clin Immunol 2006, 117:345-350.
17. Rona R. Asthma and poverty. Thorax 2000, 55:239-244.
18. Custovic A., Green R., Fletcher A., Smith A., Pickering C.A., Chapman M.D., et al. Aerodynamic properties of the major dog allergen Can f1: distribution in homes, concentration and particle size of allergen in the air. Am J Respir Crit Care Med 1997, 155:94-98.
19. Simpson A., Custovic A. Pets and the development of allergic sensitization. Current Allergy and Asthma Reports 2005, 5:212-220.
20. ARIA Workshop Report. Allergic Rhinitis and its Impact of Asthma. J Allergy Clin Immunol. 2001;108:S148-S333.
21. Leynaert B., Neukirch F., Demoly P., Bousquet J. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000, 106:S201-S205.
22. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR Study. J Investig Allergol Clin Immunol. 2008;18:233-8.
23. Genes for asthma? An analysis of the European Community Respiratory Health Survey. Am J Respir Crit Care Med 1997, 156:1773-1780. The European Community Respiratory Health Survey Group.
24. Los H., Koppelman G.H., Postma D.S. The importance of genetic influences in asthma. Eur Respir J 1999, 14:1210-1227.
25. Holloway J.W., Yang I.A., Holgate S.T. Genetics of allergic disease. J Allergy Clin Immunol 2010, 125:S81-94.
26. Haagerup A., Bjerke T., Schiotz P.O., Binderup H.G., Dahl R., Kruse T.A. Asthma and atopy-a total genome scan for susceptibility genes. Allergy 2002, 57:680-686.
27. Anees W., Moore V.C., Burge P.S. FEV1 decline in occupational asthma. Thorax 2006, 61:751-755.
28. Delclos G.L., Gimeno D., Arif A.A., Benavides F.G., Zock J.P. Occupational exposures and asthma in health-care workers: comparison of self-reports with a workplace-specific job exposure matrix. Am J Epidemiol 2009, 169:581-587.
29. Szczeklik A., Stevenson D.D. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003, 111:913-921.
30. Thomsen S.F., Kyvik K.O., Skadhauge L.R., Steffensen I., Backer V. Regular use of non-steroidal anti-inflammatory drugs increases the risk of adult-onset asthma: a population-based follow-up study. Clin Respir J 2009, 3:82-84.
31. Pasaje C.F., Kim J.H., Park B.L., Cheong H.S., Chun J.Y., Park T.J., et al. Association of SLC6A12 variants with aspirin-intolerant asthma in a Korean population. Ann Hum Genet 2010, 74:326-334.
32. Lemanske R.F., Dick E.C., Swenson C.A., Vrtis R.F., Busse W.W. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 1989, 153:743-748.
33. Grunberg K., Timmers M.C., De Klerk E.P., Dick D.C., Sterk P.J. Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am Respir Crit Care Med 1999, 160:1375-1380.
34. Sioux V., Pin I., Oryszczyn M.P., Le Moual N., Kauffmann F. Relationship of active smoking to asthma and asthma severity in the EGEA study. Epidemiological Study on the Genetics and Environment of Asthma. Eur Respir J 2000, 15:470-477.
35. Jamrozik E., Knuiman M.W., James A., Divitini M., Musk A.W. Risk factors for adult-onset asthma: A 14-year longitudinal study. Respirology 2009, 14:814-821.
36. Roorda R.J., Gerritsen J., Van Aalderen W.M., Schouten J.P., Veltman J.C., Weiss S.T., et al. Follow-up of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol 1994, 93:575-584.
37. Phelan P.D., Robertson C.F., Olinsky A. The Melbourne asthma study: 1964-1999. J Allergy Clin Immunol 2002, 109:189-194.
38. Kattan M., Kumar R., Bloomberg G.R., Mitchell H.E., Calatroni A., Gergen P.J., et al. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol 2010, 125:584-592.
39. Thomsen S.F., Ulrik C.S., Kyvik K.O., Larsen K., Skadhauge L.R., Steffensen I.E., et al. Risk factors for asthma in young adults: a co-twin control study. Allergy 2006, 61:229-233.